As Operation Warp Speed continues to unfold and the United States and the world at large wait for a vaccine for COVID-19, Big Law will play a pivotal role in virtually all of the areas that will make vaccination and treatment of the deadly virus possible. 

Multiple pharmaceutical companies, such as AstraZeneca, Pfizer, Johnson & Johnson and French drugmaker Sanofi have all been given millions, or in some cases billions, of dollars to work on vaccines in an effort to find at least one that can be validated and distributed to more than 300 million Americans. The U.S. investment in the effort now totals over $8 billion, according to the Biomedical Advanced Research and Development Authority (BARDA). 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]